Dr. Gurpreet Lamba

Brief Biography:

---

Rafiyath SM, Lamba G, Singh P, Rasul M and Liu D. Comparison of liposomal doxorubicin versus conventional anthracyclines: A meta-analysis. Journal of Clinical Oncology (Meeting Abstracts) 28 (15_suppl), e13128. Bitetto AM, Lamba G, Cadavid G, Shah D, Forlenza T, Rotatori F and Rafiyath SM. Colonic perforation secondary to chronic lymphocytic leukemia infiltration without Richter transformation. Leukemia & lymphoma 52 (5), 930. Lamba G, Rafiyath SM, Kaur H, Khan S, Singh P, Hamilton AM and Ang DC. Malignant glomus tumor of kidney: the first reported case and review of literature. Human pathology 2011; 42(8):1200-3. Lamba G, Kaur H, Adapa S, Shah D, Malhotra B.K, Rafiyath S.M, Thakar K, Fernandez A.C. Use of Conjugated Estrogens in Life-Threatening Gastrointestinal Bleeding in Hemodialysis Patients—A Review. Clinical and Applied Thrombosis/Hemostasis 2012 Mar 12 PMID: 22411999 Lamba G, Ambrale S, Gupta R, Lee B, Rafiyath SM and Liu D. Recent advances and novel agents for gastrointestinal stromal tumor (GIST) Journal of Hematology & Oncology 5 (1), 21 For a complete list of Gurpreet S Lamba’s publications, please visit Google Scholar.

Academic positions:

---

Assistant Professor - Medicine / Hematology - Oncology at University of Vermont and Fletcher Allen Health Care.

Research interests:

---

These include clinical research for treatment options and supportive care for patients with leukemia, lymphomas and other hematologic malignancies. Dr. Lamba also participates in numerous national cooperative group trials. His research has opened doors to innovative therapies for patients with blood-related cancers through his involvement in the design and conduct of Phase I, II and III clinical trials He is also interested in using novel agents so as to reduce the toxicity without compromising on efficacy in patients with hematologic malignancies.

What I think of the idea behind WebmedCentral:

---

Excellent Resource.